Renalytix PLC (AIM:RENX) shares moved up on Thursday thanks to an upbeat trading update, revealing a 20% rise in third-quarter revenue. The company, which specialises in artificial intelligence-enabled in vitro diagnostics, told investors it processed more than 1,000 billable kidneyintelX.dkd tests in the quarter.